Paolo Pucci
Direktor/Vorstandsmitglied bei WEST PHARMACEUTICAL SERVICES, INC.
Vermögen: 4 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Philip Astley-Sparke | M | 51 | 9 Jahre | |
| Robert Coffin | M | 58 | 9 Jahre | |
| Bill Lundberg | M | 60 | 5 Jahre | |
| Bernard Birkett | M | 55 | 6 Jahre | |
| Sushil Patel | M | 52 | 3 Jahre | |
| Eric Green | M | 55 | 9 Jahre | |
| Kapil Dhingra | M | 64 | 12 Jahre | |
| Peter Silverman | M | 46 | 7 Jahre | |
| Mark Iwicki | M | 57 | 9 Jahre | |
| Anand Mehra | M | 48 | 9 Jahre | |
| Dieter Weinand | M | 63 | 6 Jahre | |
| Gregory Perry | M | 63 | 8 Jahre | |
| Sushant Kumar | M | - |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Len Kanavy | M | 62 | 6 Jahre | |
| Kimberly MacKay | F | 58 | 4 Jahre | |
| Deborah Baron | F | 55 | 3 Jahre | |
| Deborah Keller | F | 61 | 7 Jahre | |
| Andrew Muratore | M | - | 3 Jahre | |
| Victor Sandor | M | 57 | 5 Jahre | |
| Christy Oliger | F | 54 | 3 Jahre | |
| Cindy Reiss-Clark | F | 50 | - | |
| Silji Abraham | M | 52 | 6 Jahre | |
| Douglas Michels | M | 66 | 13 Jahre | |
| Andrew Schwendenman | M | 47 | 4 Jahre | |
| Molly Joseph | F | 50 | 3 Jahre | |
| Veleka Peeples-Dyer | F | 52 | 1 Jahre | |
| Myla Lai-Goldman | M | 66 | 10 Jahre | |
| Stephen Lockhart | M | 65 | 2 Jahre | |
| Thomas Hofmann | M | 72 | 17 Jahre | |
| William Feehery | M | 54 | 12 Jahre | |
| Robert Glassman | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 Jahre |
| Joseph Slattery | M | 59 | 7 Jahre | |
| Mark Buthman | M | 63 | 13 Jahre | |
| Peter Molloy | M | 52 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | - |
| Hyam Levitsky | M | 66 | 6 Jahre | |
| David Epstein | M | 62 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 4 Jahre |
| Sherri L. Spear | F | - | - | |
| Robert Friel | M | 68 | 4 Jahre | |
| Konstantinos Xynos | M | 57 | 2 Jahre | |
| Michele Polinsky | M | - | - | |
| Cecilia Anna Wilhelmina Geuijen | M | 56 | 3 Jahre | |
| Robert Segura | M | - | 3 Jahre | |
| Chris Ryan | M | - | - | |
| Ernesto Wasserman | M | - | 8 Jahre | |
| Donald A. McMillan | M | 65 | 27 Jahre | |
| Shannon Campbell | F | 58 | 2 Jahre | |
| John de Kruif | M | 60 | 17 Jahre | |
| Kathleen Farren | F | - | - | |
| Andrew Joe | M | 58 | 4 Jahre | |
| Harry Shuman | M | - | - | |
| Liu Hui | M | 51 | 9 Jahre | |
| Arleen Goldenberg | F | - | - | |
| Quintin Lai | M | 57 | 8 Jahre | |
| Annette Favorite | F | 59 | 9 Jahre | |
| Paul Achleitner | M | 67 | 22 Jahre | |
| Alexander Berthold Hendrik Bakker | M | 57 | 14 Jahre | |
| Mark S. Cohen | M | 56 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| George Migausky | M | 69 | 8 Jahre | |
| Andrew Ashe | M | 57 | 13 Jahre | |
| Jean Franchi | F | 57 | 4 Jahre | |
| Gustav Christensen | M | 76 | 9 Jahre | |
| Jan Skvarka | M | 57 | 2 Jahre | |
| Patrick Zenner | M | 77 | 20 Jahre | |
| Robert A. Uger | M | 53 | 8 Jahre | |
| David J. McLachlan | M | 86 | 17 Jahre | |
| Henry E. Blair | M | 80 | 27 Jahre | |
| Robert L. Kirkman | M | 75 | 8 Jahre | |
| James Parsons | M | 58 | 10 Jahre | |
| Ivana Magovcevic-Liebisch | M | 55 | 12 Jahre | |
| Tanya Lewis | F | 53 | 4 Jahre | |
| Paul Walker | M | 49 | 1 Jahre | |
| Chad Johnson | M | 45 | - | |
| Luke Beshar | M | 65 | 7 Jahre | |
| Thomas Hoffmann | M | 53 | 5 Jahre | |
| William Federici | M | 64 | 15 Jahre | |
| Scott Myers | M | 57 | - | |
| Penka Petrova | M | 56 | 8 Jahre | |
| Pamela Esposito | M | 50 | 9 Jahre | |
| Joseph Saluri | M | 57 | 7 Jahre | |
| Willy Beumann | M | 68 | - | |
| Johannes M. Dietsch | M | 62 | 16 Jahre | |
| Helena Tayton-Martin | M | 57 | 4 Jahre | |
| Bernd Metzner | M | 53 | 4 Jahre | |
| Jason Rhodes | M | 54 | 7 Jahre | |
| Hugo Slootweg | M | 53 | 8 Jahre | |
| John Weiland | M | 68 | 12 Jahre | |
| Mary Gray | M | 71 | 12 Jahre | |
| Otello Stampacchia | M | 55 | 7 Jahre | |
| Klaus Sturany | M | 77 | - | |
| Paula Johnson | M | 64 | 16 Jahre | |
| Klaus-Christian Kleinfeld | M | 65 | 9 Jahre | |
| Paul Edick | M | 67 | 7 Jahre | |
| Helmut Gunter Wilhelm Panke | M | 77 | - | |
| Michael A. Anderson | M | 68 | 24 Jahre | |
| David Montecalvo | M | 58 | 6 Jahre | |
| Marc Kozin | M | 62 | 4 Jahre | |
| Thomas Reynolds | M | 65 | 7 Jahre | |
| Michael Kamarck | M | 73 | 1 Jahre | |
| Rosemary Harrison | M | 41 | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 34 | 34,34% |
| Schweiz | 26 | 26,26% |
| Niederlande | 17 | 17,17% |
| Kanada | 14 | 14,14% |
| Deutschland | 8 | 8,08% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Paolo Pucci
- Persönliches Netzwerk
